Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study.

Circulation - 14 Sept 1999

Kronenberg F, Kronenberg M F, Kiechl S, Trenkwalder E, Santer P, Oberhollenzer F, Egger G, Utermann G, Willeit J

Abstract excerpt

BACKGROUND: Experimental studies have suggested both atherogenic and thrombogenic properties of lipoprotein(a) [Lp(a)], depending on Lp(a) plasma concentrations and varying antifibrinolytic capacity of apolipoprotein(a) [apo(a)] isoforms. Epidemiological studies may contribute to assessment of the relevance of these findings in the general population. METHODS AND RESULTS: This study prospectively investigated the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Apolipoproteins A

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Arteriosclerosis

Share to Carotid Artery Diseases

Share to Lipoprotein(a)

Share to Phenotype

Share to Protein Isoforms

Share to Risk Factors

Source

Identifiers

PMID: 10484534
DOI: 10.1161/01.cir.100.11.1154

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study.PMID 10484534Read ↗

Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association.Semantic proximity Read ↗

Beyond Cholesterol: A Comprehensive Review and Disease Architecture Reassessment of Lipid and Lipoprotein Biomarkers in ASCVDSemantic proximity Read ↗

Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study.Semantic proximity Read ↗

Lipoprotein(a) as an Old and New Causal Risk Factor of Atherosclerotic Cardiovascular DiseaseSemantic proximity Read ↗

Lipoprotein(a): An independent, genetic, and causal factor for cardiovascular disease and acute myocardial infarctionSemantic proximity Read ↗

Lipoprotein(a) and the risk of vascular diseaseSemantic proximity Read ↗

Lipoprotein(a) as a potential causal genetic risk factor of cardiovascular disease: a rationale for increased efforts to understand its pathophysiology and develop targeted therapies.Semantic proximity Read ↗

The biology of lipoprotein(a): From genetics to molecular mechanismsSemantic proximity Read ↗

Lipoprotein(a): new insights from modern genomicsSemantic proximity Read ↗

Genetics and Pathophysiological Mechanisms of Lipoprotein(a)-Associated Cardiovascular Risk.Semantic proximity Read ↗

Associations of Genetically Predicted Lp(a) (Lipoprotein [a]) Levels With Cardiovascular Traits in Individuals of European and African Ancestry.Semantic proximity Read ↗

Discrimination and net reclassification of cardiovascular risk with lipoprotein(a): prospective 15-year outcomes in the Bruneck Study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.